InMode (INMD) Competitors $14.10 -0.32 (-2.22%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock INMD vs. SLNO, IRTC, TMDX, PRCT, NVST, LMAT, NVCR, LIVN, ENOV, and WRBYShould you be buying InMode stock or one of its competitors? The main competitors of InMode include Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), TransMedics Group (TMDX), PROCEPT BioRobotics (PRCT), Envista (NVST), LeMaitre Vascular (LMAT), NovoCure (NVCR), LivaNova (LIVN), Enovis (ENOV), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry. InMode vs. Soleno Therapeutics iRhythm Technologies TransMedics Group PROCEPT BioRobotics Envista LeMaitre Vascular NovoCure LivaNova Enovis Warby Parker Soleno Therapeutics (NASDAQ:SLNO) and InMode (NASDAQ:INMD) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, community ranking, media sentiment, risk, analyst recommendations, institutional ownership and dividends. Does the MarketBeat Community favor SLNO or INMD? Soleno Therapeutics received 158 more outperform votes than InMode when rated by MarketBeat users. Likewise, 72.62% of users gave Soleno Therapeutics an outperform vote while only 71.18% of users gave InMode an outperform vote. CompanyUnderperformOutperformSoleno TherapeuticsOutperform Votes32172.62% Underperform Votes12127.38% InModeOutperform Votes16371.18% Underperform Votes6628.82% Does the media favor SLNO or INMD? In the previous week, InMode had 18 more articles in the media than Soleno Therapeutics. MarketBeat recorded 30 mentions for InMode and 12 mentions for Soleno Therapeutics. Soleno Therapeutics' average media sentiment score of 1.23 beat InMode's score of -0.03 indicating that Soleno Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Soleno Therapeutics 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InMode 3 Very Positive mention(s) 5 Positive mention(s) 10 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Is SLNO or INMD more profitable? InMode has a net margin of 45.91% compared to Soleno Therapeutics' net margin of 0.00%. InMode's return on equity of 18.25% beat Soleno Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Soleno TherapeuticsN/A -61.99% -55.21% InMode 45.91%18.25%16.33% Do insiders and institutionals hold more shares of SLNO or INMD? 97.4% of Soleno Therapeutics shares are owned by institutional investors. Comparatively, 68.0% of InMode shares are owned by institutional investors. 12.3% of Soleno Therapeutics shares are owned by insiders. Comparatively, 6.9% of InMode shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has better valuation and earnings, SLNO or INMD? InMode has higher revenue and earnings than Soleno Therapeutics. Soleno Therapeutics is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSoleno TherapeuticsN/AN/A-$38.99M-$4.26-17.58InMode$394.82M2.48$181.27M$2.356.00 Which has more risk and volatility, SLNO or INMD? Soleno Therapeutics has a beta of -2.29, indicating that its stock price is 329% less volatile than the S&P 500. Comparatively, InMode has a beta of 1.96, indicating that its stock price is 96% more volatile than the S&P 500. Do analysts recommend SLNO or INMD? Soleno Therapeutics currently has a consensus target price of $104.67, indicating a potential upside of 39.72%. InMode has a consensus target price of $18.54, indicating a potential upside of 31.50%. Given Soleno Therapeutics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Soleno Therapeutics is more favorable than InMode.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Soleno Therapeutics 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 3.20InMode 0 Sell rating(s) 7 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.13 SummarySoleno Therapeutics and InMode tied by winning 9 of the 18 factors compared between the two stocks. Get InMode News Delivered to You Automatically Sign up to receive the latest news and ratings for INMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INMD vs. The Competition Export to ExcelMetricInModeElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$980.78M$3.18B$5.54B$7.76BDividend YieldN/A1.80%5.11%4.22%P/E Ratio6.0015.3522.3918.43Price / Sales2.4852.73394.53103.63Price / Cash10.4044.0938.1834.62Price / Book1.393.516.764.23Net Income$181.27M$94.03M$3.22B$248.23M7 Day Performance-9.50%4.40%2.99%3.08%1 Month Performance-20.34%2.41%-0.22%2.24%1 Year Performance-17.98%-16.49%17.90%5.35% InMode Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INMDInMode3.4057 of 5 stars$14.10-2.2%$18.54+31.5%-18.0%$980.78M$394.82M6.00480Earnings ReportAnalyst ForecastOptions VolumeNews CoverageSLNOSoleno Therapeutics4.6454 of 5 stars$73.64+0.5%$104.67+42.1%+67.6%$3.68BN/A-22.1830Upcoming EarningsPositive NewsGap DownIRTCiRhythm Technologies0.9754 of 5 stars$106.64+0.6%$119.73+12.3%-2.5%$3.40B$591.84M-29.301,790News CoveragePositive NewsTMDXTransMedics Group3.0328 of 5 stars$90.19-3.5%$122.70+36.0%-2.3%$3.05B$441.54M95.95210Upcoming EarningsAnalyst ForecastGap DownPRCTPROCEPT BioRobotics2.7239 of 5 stars$54.16+3.2%$90.00+66.2%+1.9%$2.97B$249.12M-27.77430Earnings ReportAnalyst RevisionPositive NewsNVSTEnvista4.4284 of 5 stars$15.97+0.2%$19.96+25.0%-18.3%$2.75B$2.51B-2.4612,700Analyst ForecastLMATLeMaitre Vascular2.1696 of 5 stars$91.54-0.1%$98.14+7.2%+40.0%$2.07B$219.86M50.02490Upcoming EarningsPositive NewsNVCRNovoCure3.7362 of 5 stars$18.31-1.0%$32.83+79.3%+48.2%$2.04B$605.22M-13.081,320Earnings ReportLIVNLivaNova3.8183 of 5 stars$37.51+0.7%$61.17+63.1%-33.6%$2.04B$1.25B89.312,900Upcoming EarningsPositive NewsENOVEnovis2.7286 of 5 stars$34.67-1.2%$58.50+68.7%-37.4%$1.98B$2.11B-15.836,800Upcoming EarningsPositive NewsWRBYWarby Parker3.8517 of 5 stars$15.47-0.3%$22.93+48.2%+40.7%$1.60B$771.32M-57.303,030Upcoming EarningsAnalyst Upgrade Related Companies and Tools Related Companies SLNO Alternatives IRTC Alternatives TMDX Alternatives PRCT Alternatives NVST Alternatives LMAT Alternatives NVCR Alternatives LIVN Alternatives ENOV Alternatives WRBY Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INMD) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMode Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INMD Stock Free INMD Stock Alerts